Hepatitis Monthly

Published by: Kowsar

The Relationship Between 25-Hydroxyvitamin D3 and Hepatitis B Surface Antigen Levels in Patients with Chronic Hepatitis B in Japan

Norio Itokawa 1 , Masanori Atsukawa 1 , 2 , * , Akihito Tsubota 3 , Hiroshi Abe 4 , Noritomo Shimada 5 , Tomomi Okubo 1 , Taeang Arai 1 , Ai Nakagawa 1 , Chisa Kondo 1 , Yoshio Aizawa 4 and Katsuhiko Iwakiri 2
Authors Information
1 Division of Gastroenterology, Department of Internal Medicine, Nippon Medical School Chiba Hokusoh Hospital, Chiba, Japan
2 Division of Gastroenterology and Hepatology, Department of Internal Medicine, Nippon Medical School, Tokyo, Japan
3 Core Research Facilities for Basic Science, Research Center for Medical Sciences, The Jikei University School of Medicine, Tokyo, Japan
4 Division of Gastroenterology and Hepatology, The Jikei University School of Medicine Katsusika Medical Center, Tokyo, Japan
5 Division of Gastroenterology and Hepatology, Otakanomori Hospital, Kashiwa, Chiba, Japan
Article information
  • Hepatitis Monthly: May 2018, 18 (5); e63587
  • Published Online: May 1, 2018
  • Article Type: Research Article
  • Received: November 3, 2017
  • Revised: March 16, 2018
  • Accepted: March 28, 2018
  • DOI: 10.5812/hepatmon.63587

To Cite: Itokawa N, Atsukawa M, Tsubota A, Abe H, Shimada N, et al. The Relationship Between 25-Hydroxyvitamin D3 and Hepatitis B Surface Antigen Levels in Patients with Chronic Hepatitis B in Japan, Hepat Mon. 2018 ; 18(5):e63587. doi: 10.5812/hepatmon.63587.

Copyright © 2018, Hepatitis Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. World Health Organization . Hepatitis B. Fact Sheet No.204. 2013.
  • 2. Dienstag JL. Hepatitis B virus infection. N Engl J Med. 2008;359(14):1486-500. doi: 10.1056/NEJMra0801644. [PubMed: 18832247].
  • 3. Tseng TC, Liu CJ, Yang HC, Su TH, Wang CC, Chen CL, et al. High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load. Gastroenterology. 2012;142(5):1140-1149 e3. quiz e13-4. doi: 10.1053/j.gastro.2012.02.007. [PubMed: 22333950].
  • 4. Tang BM, Eslick GD, Nowson C, Smith C, Bensoussan A. Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet. 2007;370(9588):657-66. doi: 10.1016/S0140-6736(07)61342-7. [PubMed: 17720017].
  • 5. Nagpal S, Na S, Rathnachalam R. Noncalcemic actions of vitamin D receptor ligands. Endocr Rev. 2005;26(5):662-87. doi: 10.1210/er.2004-0002. [PubMed: 15798098].
  • 6. Manuel Quesada J, Solana R, Serrano I, Barrio V, Martinez ME, Santamaria M, et al. Immunologic effects of vitamin D. N Engl J Med. 1989;321(12):833-4. doi: 10.1056/NEJM198909213211215. [PubMed: 2597268].
  • 7. Salahuddin N, Ali F, Hasan Z, Rao N, Aqeel M, Mahmood F. Vitamin D accelerates clinical recovery from tuberculosis: results of the SUCCINCT Study [Supplementary Cholecalciferol in recovery from tuberculosis]. A randomized, placebo-controlled, clinical trial of vitamin D supplementation in patients with pulmonary tuberculosis'. BMC Infect Dis. 2013;13:22. doi: 10.1186/1471-2334-13-22. [PubMed: 23331510].
  • 8. Ginde AA, Scragg R, Schwartz RS, Camargo CJ. Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults. J Am Geriatr Soc. 2009;57(9):1595-603. doi: 10.1111/j.1532-5415.2009.02359.x. [PubMed: 19549021].
  • 9. Boucher BJ, Mannan N, Noonan K, Hales CN, Evans SJ. Glucose intolerance and impairment of insulin secretion in relation to vitamin D deficiency in east London Asians. Diabetologia. 1995;38(10):1239-45. doi: 10.1007/BF00422375. [PubMed: 8690178].
  • 10. Giovannucci E, Liu Y, Rimm EB, Hollis BW, Fuchs CS, Stampfer MJ, et al. Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst. 2006;98(7):451-9. doi: 10.1093/jnci/djj101. [PubMed: 16595781].
  • 11. Atsukawa M, Tsubota A, Shimada N, Yoshizawa K, Abe H, Asano T, et al. Influencing factors on serum 25-hydroxyvitamin D3 levels in Japanese chronic hepatitis C patients. BMC Infect Dis. 2015;15:344. doi: 10.1186/s12879-015-1020-y. [PubMed: 26286329].
  • 12. Petta S, Camma C, Scazzone C, Tripodo C, Di Marco V, Bono A, et al. Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C. Hepatology. 2010;51(4):1158-67. doi: 10.1002/hep.23489. [PubMed: 20162613].
  • 13. Atsukawa M, Tsubota A, Shimada N, Kondo C, Itokawa N, Nakagawa A, et al. Efficacy of Alfacalcidol on PEG-IFN/ Ribavirin Combination Therapy for Elderly Patients With Chronic Hepatitis C: A Pilot Study. Hepat Mon. 2013;13(12). e14872. doi: 10.5812/hepatmon.14872. [PubMed: 24403915].
  • 14. Farnik H, Bojunga J, Berger A, Allwinn R, Waidmann O, Kronenberger B, et al. Low vitamin D serum concentration is associated with high levels of hepatitis B virus replication in chronically infected patients. Hepatology. 2013;58(4):1270-6. doi: 10.1002/hep.26488. [PubMed: 23703797].
  • 15. Yu R, Sun J, Zheng Z, Chen J, Fan R, Liang X, et al. Association between vitamin D level and viral load or fibrosis stage in chronic hepatitis B patients from Southern China. J Gastroenterol Hepatol. 2015;30(3):566-74. doi: 10.1111/jgh.12783. [PubMed: 25238258].
  • 16. Chan HL, Elkhashab M, Trinh H, Tak WY, Ma X, Chuang WL, et al. Association of baseline vitamin D levels with clinical parameters and treatment outcomes in chronic hepatitis B. J Hepatol. 2015;63(5):1086-92. doi: 10.1016/j.jhep.2015.06.025. [PubMed: 26143444].
  • 17. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357(3):266-81. doi: 10.1056/NEJMra070553. [PubMed: 17634462].
  • 18. Martinez SM, Crespo G, Navasa M, Forns X. Noninvasive assessment of liver fibrosis. Hepatology. 2011;53(1):325-35. doi: 10.1002/hep.24013. [PubMed: 21254180].
  • 19. Marcellin P, Ziol M, Bedossa P, Douvin C, Poupon R, de Ledinghen V, et al. Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B. Liver Int. 2009;29(2):242-7. doi: 10.1111/j.1478-3231.2008.01802.x. [PubMed: 18637064].
  • 20. Jablonski KL, Jovanovich A, Holmen J, Targher G, McFann K, Kendrick J, et al. Low 25-hydroxyvitamin D level is independently associated with non-alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis. 2013;23(8):792-8. doi: 10.1016/j.numecd.2012.12.006. [PubMed: 23415456].
  • 21. Targher G, Bertolini L, Scala L, Cigolini M, Zenari L, Falezza G, et al. Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis. 2007;17(7):517-24. doi: 10.1016/j.numecd.2006.04.002. [PubMed: 16928437].
  • 22. Chen EQ, Bai L, Zhou TY, Fe M, Zhang DM, Tang H. Sustained suppression of viral replication in improving vitamin D serum concentrations in patients with chronic hepatitis B. Sci Rep. 2015;5:15441. doi: 10.1038/srep15441. [PubMed: 26486883].
  • 23. Tsiaras WG, Weinstock MA. Factors influencing vitamin D status. Acta Derm Venereol. 2011;91(2):115-24. doi: 10.2340/00015555-0980. [PubMed: 21384086].
  • 24. Kimura T, Rokuhara A, Sakamoto Y, Yagi S, Tanaka E, Kiyosawa K, et al. Sensitive enzyme immunoassay for hepatitis B virus core-related antigens and their correlation to virus load. J Clin Microbiol. 2002;40(2):439-45. doi: 10.1128/JCM.40.2.439-445.2002. [PubMed: 11825954].
  • 25. Limothai U, Chuaypen N, Khlaiphuengsin A, Chittmittraprap S, Poovorawan Y, Tangkijvanich P. Association of vitamin-D-related genetic variations and treatment response to pegylated interferon in patients with chronic hepatitis B. Antivir Ther. 2017;22(8):681-8. doi: 10.3851/IMP3154. [PubMed: 28291736].
  • 26. Bandeira F, Griz L, Dreyer P, Eufrazino C, Bandeira C, Freese E. Vitamin D deficiency: A global perspective. Arq Bras Endocrinol Metabol. 2006;50(4):640-6. doi: 10.1590/S0004-27302006000400009. [PubMed: 17117289].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments